New Investigator Joins Basic Science Division at Fox Chase Cancer Center
PHILADELPHIA (May 27, 2005) - Alexei Tulin has joined the division of basic science at Fox Chase Cancer Center as an associate member. Tulin studies the abundant nuclear enzyme poly(ADP-ribose) polymerase (PARP) and how it plays novel and previously unknown roles in many processes, including transcriptional activation of genes and the initiation and maintenance of nucleoli and telomere metabolism. Telomeres are specialized structures at the ends of chromosomes, the rod-like structures that carry genes.
Tulin comes to Fox Chase from Howard Hughes Medical Institute at Carnegie Institution of Washington in Baltimore, Md., where he was a postdoctoral researcher in the department of embryology since 1998. Before that, Tulin completed a one-year postdoctoral fellowship in the department of molecular biology at Russia's Moscow State University.
After receiving his bachelor's degree in biology there in 1993, Tulin earned his Ph.D. in molecular biology from Moscow State in 1997.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.